U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680413) titled 'Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria' on June 06.
Brief Summary: This is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin/Histamine Complex (IHC) in patients with Chronic Urticaria in India.
Study Start Date: Dec. 31, 2025
Study Type: OBSERVATIONAL
Condition:
Chronic Urticaria
Intervention:
DRUG: Antihistaminics, H2 blockers, Leukotriene antagonists, Immunoglobulin/Histamine Complex (IHC) Injection
Histaglobulin prefilled syringe is adm...